Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical Tools
Francesca D'Amico1, Cami M P Talavera Ormeño1, Shivanganie Poeran1
1Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC), Einthovenweg 20, 2333 ZC, Leiden, The Netherlands.
Abstract:
The Ubiquitin-like protein FUBI is encoded in humans by the FAU gene, whose down-regulation in prostate, ovarian and breast cancer is significantly associated with poor prognosis. Despite its implications in disease progression, the regulatory mechanisms orchestrated by FUBI remain elusive. To address this knowledge gap, a linear synthetic platform is developed to generate FUBI chemical tools, enabling the site-specific incorporation of unnatural building blocks and the introduction of fluorophores, tags, and reactive warheads. Using this platform, activity-based probes are created for FUBI conjugation and deconjugation enzymes, validating them in cell lysate-based assays and proteomics. Additionally, a triazole-linked Di-FUBI is synthesized to investigate FUBI chain modulators. Among the proteomics hits, IMPDH1 and the deubiquitinase UCHL3 are identified as novel Di-FUBI specific interactors. Further characterization revealed that Di-FUBI inhibits UCHL3 cleavage activity in a concentration-dependent manner, suggesting a novel regulatory interplay between UCHL3 and FUBI. Collectively, these tools demonstrate the versatility of the synthetic FUBI platform, advancing the characterization of FUBI-related enzymes in the ongoing efforts to decipher the complex code of ubiquitin-like signaling.
Insights
Researchers developed novel chemical tools to study the Ubiquitin-like protein FUBI (FUBI). These tools revealed new interactions and showed FUBI can inhibit UCHL3 activity, offering insights into cancer progression.
Area of Science:
- Biochemistry
- Chemical Biology
- Molecular Oncology
Background:
- The Ubiquitin-like protein FUBI, encoded by the FAU gene, is downregulated in several cancers, correlating with poor prognosis.
- The precise regulatory mechanisms of FUBI in disease progression are not well understood.
Purpose of the Study:
- To develop a synthetic platform for generating FUBI chemical tools.
- To investigate FUBI conjugation and deconjugation enzymes and identify novel FUBI interactors.
Main Methods:
- A linear synthetic platform was established for site-specific incorporation of unnatural building blocks, fluorophores, tags, and reactive warheads into FUBI.
- Activity-based probes were synthesized and validated in cell lysate assays and proteomics.
- A triazole-linked Di-FUBI was created to study FUBI chain modulators.
Main Results:
- The synthetic platform successfully generated FUBI chemical tools.
- Proteomics identified IMPDH1 and the deubiquitinase UCHL3 as novel Di-FUBI specific interactors.
- Di-FUBI was found to inhibit UCHL3 cleavage activity in a concentration-dependent manner.
Conclusions:
- The developed synthetic FUBI platform is versatile for creating chemical biology tools.
- Novel interactions and regulatory roles of FUBI, including inhibition of UCHL3, were uncovered.
- These findings advance the understanding of ubiquitin-like signaling in cancer.
Related Concept Videos
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Tagging and Fusion Proteins


